CTOs on the Move

Anthelio Healthcare

www.antheliohealth.com

 
Anthelio Healthcare Solutions Inc. is much more than a healthcare IT company. We are a single source provider of world-class technology solutions for the healthcare industry with a 15-year history of excellence. Our innovative services and products make it easier for our customers to do what they do best – deliver outstanding patient care. Our company was built on the foundation that healthcare is our only business, uniquely positioning us as one of the very few companies who focus solely on the needs of our healthcare customers and their patients. We take great pride in maintaining the highest levels of ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Haupt Pharma

Haupt Pharma is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GRAND Mental Health

GRAND Mental Health is a nonprofit community behavioral health center that provides mental health care services to adults, children, and families in Northeast Oklahoma.

Dramatic Health

Since its founding in 2005, Dramatic Health has stood at the forefront of high quality healthcare video production, and the online/mobile distribution of those assets.

Heritage At Falmouth

Heritage At Falmouth is a Falmouth, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Iterative Health

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.